Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Insulin delivery devices industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 End-use trends
Chapter 3 Insulin Delivery Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of diabetes
3.2.1.2 Technological advancements in insulin delivery devices
3.2.1.3 Increasing diabetes care expenditure
3.2.1.4 Favourable device insurance and reimbursement policies
3.2.1.5 Adoption of facilitative initiatives
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of insulin pumps
3.2.2.2 High out-of-pocket expenditure in developing countries
3.2.2.3 Stringent government regulations
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Future market trends
3.9 Gap analysis
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis, 2022
4.6 Strategy dashboard, 2022
Chapter 5 Insulin Delivery Devices Market Size and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Insulin Pumps
5.2.1 Tubed/tethered
5.2.2 Tubeless
5.3 Insulin Pens
5.3.1 Reusable
5.3.2 Disposable
5.4 Insulin Pen needles
5.4.1 Safety
5.4.2 Standard
5.5 Insulin Jet injectors
5.6 Insulin Syringes
5.7 Others
Chapter 6 Insulin Delivery Devices Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Home care
6.3 Hospitals & clinics
6.4 Others
Chapter 7 Insulin Clearance Devices Market Size and Forecast, By Region (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 Egypt
Chapter 8 Company Profiles
8.1 Novo Nordisk A/S
8.2 Ypsomed Holdings AG
8.3 Medtronic plc
8.4 Tandem Diabetes Care
8.5 Sanofi
8.6 Biocon
8.7 Eli Lilly & Company
8.8 Insulet Corporation
8.9 Roche
8.10 B Braun Melsungen AG
8.11 Microport
8.12 Medtrum Technologies
8.13 Arkray
8.14 A. Menarini Diagnostics
8.15 Terumo Corporation
8.16 Nipro Corporation
8.17 KDL Medical
8.18 KDL Medical
8.19 Zealand Pharma
8.20 ViCentra B.V.
8.21 Julphar Pharmaceuticals
